Günter Feick

Günter Feick

Auto-generated profile, based on publicly available information

Günter Feick

Federal Association of German Prostate Cancer Patient Support Groups, Bonn, Germany

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2015 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
CKChristoph Kowalski
Christoph Kowalski
JFJulia Ferencz
Julia Ferencz
PAPeter Albers
Peter Albers
JFJan Fichtner
Jan Fichtner
TWThomas Wiegel
Thomas Wiegel
SWSimone Wesselmann
Simone Wesselmann

26 March 2022 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
NSNora Tabea Sibert
Nora Tabea Sibert
Holger PfaffHolger Pfaff
Holger Pfaff
CBClara Breidenbach
Clara Breidenbach
SWSimone Wesselmann
Simone Wesselmann
RRRebecca Roth
Rebecca Roth
CKChristoph Kowalski
Christoph Kowalski

25 September 2023 in Die Urologie
Verified
Journal Article
Closed access
PDF file
CKChristoph Kowalski
Christoph Kowalski
NSNora Tabea Sibert
Nora Tabea Sibert
PHPeter Hammerer
Peter Hammerer
SWSimone Wesselmann
Simone Wesselmann
GFGünter Feick
Günter Feick
MBMartin Burchardt
Martin Burchardt

10 February 2020 in World Journal of Urology
Verified
Journal Article
Open access
PDF file
RRRebecca Roth
Rebecca Roth
SDSebastian Dieng
Sebastian Dieng
AOAlisa Oesterle
Alisa Oesterle
GFGünter Feick
Günter Feick
GCGünther Carl
Günther Carl
CKChristoph Kowalski
Christoph Kowalski
Purpose: The self-reported functional status (sr-FS) of prostate cancer (PCa) patients varies substantially between patients and health-care providers before treatment. Information about this issue is important for evaluating comparisons between health-care providers and to assist in treatment decision-making. There have been few reports on correlates of pretherapeutic sr-FS. The objective of the article, therefore, is to describe clinical and sociodemographic correlates of pretherapeutic sr-FS, based on a subset of the TrueNTH Global Registry, a prospective cohort study. Methods: A total of 3094 PCa patients receiving local treatment in 44 PCa centers in Germany were recruited between July 2016 and April 2018. Multilevel regression models were applied to predict five pretherapeutic sr-FS (EPIC-26) scores based on clinical characteristics (standard set suggested by the International Consortium for Health Outcomes Measurement), sociodemographic characteristics, and center characteristics. Results: Impaired pretherapeutic sr-FS tended to be associated with lower educational level and poorer disease characteristics—except for “urinary incontinence” which was only associated with age. Notably, age was a risk factor (“urinary incontinence,” “urinary irritative/obstructive,” “sexual”) as well as a protective factor (“hormonal”) for pretherapeutic sr-FS. Pretherapeutic sr-FS varies little across centers. Conclusions: Pretherapeutic sr-FS varies by clinical patient characteristics and age as well as by socioeconomic status. The findings point out the benefit of collecting and considering socioeconomic information in addition to clinical and demographic patient characteristics for treatment decision-making and fair comparisons between health-care providers.

16 June 2020 in Strahlentherapie und Onkologie
Verified
Journal Article
Closed access
PDF file
CKChristoph Kowalski
Christoph Kowalski
GCGünther Carl
Günther Carl
GFGünter Feick
Günter Feick
SWSimone Wesselmann
Simone Wesselmann

4 November 2021 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
CBClara Breidenbach
Clara Breidenbach
LALena Ansmann
Lena Ansmann
NSNora Tabea Sibert
Nora Tabea Sibert
SWSimone Wesselmann
Simone Wesselmann
SDSebastian Dieng
Sebastian Dieng
CKChristoph Kowalski
Christoph Kowalski